4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-062527
Chief Executive Officer sold 7,800 shares at an average $42.66 ($332,709)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-12-12 | Sale | −3,900 | $42.56 | $165,984 | 23,578 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-12-13 | Sale | −3,900 | $42.75 | $166,725 | 19,678 | I: show line 2 in the form |
| Open-market sales · 7,800 sh · avg $42.66 · $332,709 | |||||||
Loading xslF345X03/doc4.xml…